Cases 41 - 50 of 146
AstraZeneca AB et al v. Mylan Pharmaceuticals Inc. et al
as 1:2018cv01562
Plaintiff:
AstraZeneca Pharmaceuticals LP and AstraZeneca AB
Defendant:
Mylan Inc., Mylan N.V., Mylan Laboratories Limited and others
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
as 1:2018cv01043
Defendant:
Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant:
Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Forest Laboratories Holdings, Ltd. et al v. Mylan Pharmaceuticals Inc.
as 1:2018cv00482
Plaintiff:
Forest Laboratories Holdings, Ltd. , Allergan USA, Inc. , Allergan Sales, LLC and others
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Delcor Asset Corporation et al v. Glenmark Pharmaceuticals Limited et al
as 1:2018cv00460
Plaintiff:
Delcor Asset Corporation and Mylan Pharmaceuticals Inc.
Defendant:
Glenmark Pharmaceuticals Limited , Glenmark Pharmaceuticals Inc., USA and Stiefel West Coast, LLC
Cause Of Action: 35 U.S.C. § 145
Noven Pharmaceuticals, Inc. v. Mylan Technologies Inc. et al
as 1:2017cv01777
Plaintiff:
Noven Pharmaceuticals, Inc.
Defendant:
Mylan Technologies Inc. , Mylan Pharmaceuticals Inc. , Mylan Inc. and others
Cause Of Action: 35 U.S.C. § 271
Forest Laboratories, LLC et al v. Mylan Pharmaceuticals Inc.
as 1:2017cv01728
Plaintiff:
Forest Laboratories, LLC , Forest Laboratories Holdings, Ltd. , Allergan USA Inc. and others
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
ViiV Healthcare Company et al v. Mylan Pharmaceuticals Inc. et al
as 1:2017cv01671
Plaintiff:
ViiV Healthcare Company , Shionogi & Co., Ltd. and ViiV Healthcare UK (No. 3) Limited
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271
Delcor Asset Corporation et al v. Glenmark Pharmaceuticals Limited et al
as 1:2017cv01653
Plaintiff:
Delcor Asset Corporation and Mylan Pharmaceuticals Inc.
Defendant:
Glenmark Pharmaceuticals Limited , Glenmark Pharmaceuticals Inc., USA and Stiefel West Coast, LLC
Cause Of Action: 35 U.S.C. § 271
Delcor Asset Corporation et al v. Taro Pharmaceutical Industries, Ltd. et al
as 1:2017cv00970
Plaintiff:
Delcor Asset Corporation and Mylan Pharmaceuticals Inc.
Defendant:
Taro Pharmaceutical Industries, Ltd. , Taro Pharmaceuticals U.S.A., Inc. and Stiefel West Coast, LLC
Cause Of Action: 35 U.S.C. § 145
Bayer Intellectual Property GmbH et al v. Mylan Pharmaceuticals Inc.
as 1:2017cv00584
Plaintiff:
Bayer Intellectual Property GmbH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
